Docking and chemoinformatic screens for new ligands and targets

Area of Science:

• Computational chemistry
• Drug discovery
• Pharmacology

Background:

• Computer-based docking screens are widely used for identifying ligands for known protein structures.
• Recent advancements include predicting substrates for enzymes with unknown functions.
• The rise of GPCR structures has enabled structure-based drug design.

Purpose of the Study:

• To review the current applications and comparative performance of computer-based docking screens.
• To highlight the integration of docking with empirical screening methods.
• To introduce and evaluate the pharmacological network approach as a complementary strategy.

Main Methods:

• Structure-based virtual screening using molecular docking.
• Comparison of docking hit rates with empirical high-throughput screening data.
• Pharmacological network analysis based on ligand chemical patterns.

Main Results:

• Docking screens have successfully identified ligands for over 20 proteins in the past two years.
• GPCRs, a key drug target class, show high hit rates and potent molecules via docking.
• The pharmacological network approach has proven effective in predicting drug off-targets.

Conclusions:

• Computer-based docking is a powerful tool for ligand discovery and substrate prediction.
• Integrating docking with high-throughput screening optimizes drug discovery pipelines.
• Pharmacological network analysis offers a novel perspective for understanding drug-target interactions.